Lifecore Biomedical, Inc. De (LFCR) Equity Ratio (2011 - 2025)

Lifecore Biomedical's Equity Ratio history runs 15 years deep, the most recent figure standing at 0.01 for Q2 2025.

• In Q2 2025, Equity Ratio fell 87.47% year-over-year to 0.01; the TTM figure through May 2025 stood at 0.01 (down 87.47% YoY), while the FY2025 annual figure was 0.01, down 87.47% from the prior year.
• Equity Ratio was 0.01 for Q2 2025 at Lifecore Biomedical, down from 0.01 in the prior quarter.
• In the past five years, Equity Ratio ranged from a high of 0.44 in Q1 2022 to a low of 0.06 in Q3 2023.
• Historically, Equity Ratio has averaged 0.18 across 5 years, with a median of 0.11 in 2023.
• The sharpest annual moves came in 2023 and 2024: Equity Ratio plunged 118.88% in 2023, then jumped 946.45% in 2024.
• A 5-year view of Equity Ratio shows it stood at 0.37 in 2021, then sank by 30.12% to 0.26 in 2022, then tumbled by 97.76% to 0.01 in 2023, then surged by 946.45% to 0.06 in 2024, then plunged by 90.77% to 0.01 in 2025.
• The last three Equity Ratio figures came in at 0.01 (Q2 2025), 0.01 (Q1 2025), and 0.06 (Q4 2024), per Business Quant data.